Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination product containing beclomethasone, a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties, and vitamin E (tocopherol), an essential fat-soluble antioxidant. Beclomethasone acts by suppressing the activity of various inflammatory cells (such as mast cells, eosinophils, basophils, lymphocytes, macrophages, and neutrophils) and inhibiting the release of inflammatory mediators including histamine, eicosanoids, leukotrienes, and cytokines[2][3]. Vitamin E functions primarily as an antioxidant that protects cell membranes from oxidative damage. This combination may be used topically or in other formulations to leverage both anti-inflammatory effects (from beclomethasone) and skin barrier protection/antioxidant effects (from vitamin E). The specific indications for this exact combination are not well established in major regulatory databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on beclomethasone + vitamin e.